文献速递冠心病心力衰竭与心肌病

重度左室射血分数降低患者PCI与CABG长期结局比较

Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
PubMed 文献 · JAMA Cardiol · 2020-01-01

该回顾性队列研究纳入加拿大安大略省2008至2016年LVEF低于35%且接受PCI或CABG的冠心病患者,经倾向评分匹配后各2397例,中位随访5.2年。结果显示PCI组全因死亡率、心血管死亡、MACE及再次血运重建等均显著高于CABG组。

要点

  • LVEF<35%患者中,PCI组全因死亡率显著高于CABG组(HR 1.6)。
  • PCI组MACE风险为CABG组的2.0倍,再次血运重建风险为3.7倍。
  • 研究结果可为该类患者血运重建决策提供参考。

核心结论

  • 在LVEF低于35%且接受血运重建的患者中,PCI组全因死亡率和MACE发生率均高于CABG组。

研究设计与样本

  • 纳入40至84岁、LVEF低于35%且存在左前降支、左主干或多支冠脉病变并接受PCI或CABG的患者。
  • 经30项基线特征倾向评分匹配后,PCI组2397例、CABG组2397例,中位随访5.2年(IQR 5.0-5.3)。

主要发现

  • PCI组全因死亡率显著高于CABG组(HR 1.6,95%CI 1.3-1.7)。
  • PCI组心血管死亡风险高于CABG组(HR 1.4,95%CI 1.1-1.6)。
  • PCI组MACE风险高于CABG组(HR 2.0,95%CI 1.9-2.2)。
  • PCI组再次血运重建风险高于CABG组(HR 3.7,95%CI 3.2-4.3)。
  • PCI组因MI住院(HR 3.2,95%CI 2.6-3.8)和因心衰住院(HR 1.5,95%CI 1.3-1.6)风险均高于CABG组。

临床怎么用

  • 对于LVEF低于35%且解剖适合手术的冠心病患者,CABG可能与更优的长期生存和更低的MACE风险相关。
  • 临床决策时应综合考虑血运重建方式对长期死亡率、再次血运重建及心衰住院风险的影响。

局限性

  • 本研究为回顾性队列研究,即使经过倾向评分匹配仍可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Data are lacking on the outcomes of patients with severely reduced left ventricular ejection fraction (LVEF) who undergo revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). OBJECTIVE: To compare the long-term outcomes in patients undergoing revascularization by PCI or CABG. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study performed in Ontario, Canada, from October 1, 2008, and December 31, 2016, included data from Ontario residents between 40 and 84 years of age with LVEFs less than 35% and left anterior descending (LAD), left main, or multivessel coronary artery disease (with or without LAD involvement) who underwent PCI or CABG. Exclusion criteria were concomitant procedures, previous CABG, metastatic cancer, dialysis, CABG and PCI on the same day, and emergency revascularization within 24 hours of a myocardial infarction (MI). Data analysis was performed from June 2, 2018, to December 28, 2018. EXPOSURES: Revascularization by PCI or CABG. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality. Secondary outcomes were death from cardiovascular disease, major adverse cardiovascular events (MACE; defined as stroke, subsequent revascularization, and hospitalization for MI or heart failure), and each of the individual MACE. RESULTS: A total of 12 113 patients (mean [SD] age, 64.8 (11.0) years for the PCI group and 65.6 [9.7] years for the CABG group; 5084 (72.5%) male for the PCI group and 4229 (82.9%) male for the PCI group) were propensity score matched on 30 baseline characteristics: 2397 patients undergoing PCI and 2397 patients undergoing CABG. The median follow-up was 5.2 years (interquartile range, 5.0-5.3). Patients who received PCI had significantly higher rates of mortality (hazard ratio [HR], 1.6; 95% CI, 1.3-1.7), death from cardiovascular disease (HR 1.4, 95% CI, 1.1-1.6), MACE (HR, 2.0; 95% CI, 1.9-2.2), subsequent revascularization (HR, 3.7; 95% CI, 3.2-4.3), and hospitalization for MI (HR, 3.2; 95% CI, 2.6-3.8) and heart failure (HR, 1.5; 95% CI, 1.3-1.6) compared with matched patients who underwent CABG. CONCLUSIONS AND RELEVANCE: In this study, higher rates of mortality and MACE were seen in patients who received PCI compared with those who underwent CABG. The findings may provide insight to physicians who are involved in decision-making for these patients.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Sun LY, Gaudino M, Chen RJ, et al. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting. JAMA Cardiol. 2020. PMID: 32267465. doi:10.1001/jamacardio.2020.0239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。